心肺用自己輸血装置の世界市場2016-2020

◆英語タイトル:Global Cardiopulmonary Autotransfusion Systems Market 2016-2020
◆商品コード:IRTNTR9485
◆発行会社(調査会社):Technavio
◆発行日:2016年6月17日
◆ページ数:65
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥277,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥333,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥444,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、心肺用自己輸血装置の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、心肺用自己輸血装置の世界市場規模及び予測、需要先別分析、地域別分析/市場規模、市場の成長要因、市場の課題、コスト分析、市場動向、競争状況などの情報をお届けいたします。
【レポートの概要】

About the Cardiopulmonary Autotransfusion Systems Market
Autotransfusion involves the collection of blood before surgeries and its transfusion during cardiac operations. This procedure is processed in autotransfusion systems that help minimize blood loss by collecting and filtering the RBCs, and reinfusing the blood into an individual.

Autotransfusion is an autologous technology involving the retransfusion of a person’s own blood, which increases the need for traditional centrifuge devices for separating the RBCs from the blood. Advances in technology have led companies to integrate ultrafiltration technique for blood collection. For instance, Advancis Surgical’s ultrafiltration-based HemoSep system can improve patient recovery time by filtering inflammatory molecules, preserving normal clotting function, and maintaining platelet populations.

Technavio’s analysts forecast the global cardiopulmonary autotransfusion systems to grow at a CAGR of 1.91% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global cardiopulmonary autotransfusion systems for 2016-2020. To calculate the market size, Technavio considers the revenue generated from the total consumption of cardiopulmonary autotransfusion systems globally. These systems help reduce the risk of infections that can occur due to the use of allogenic blood.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio’s report, Global Cardiopulmonary Autotransfusion Systems Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Advancis Surgical
• Fresenius Kabi
• Haemonetics
• LivaNova
• Medtronic
• Terumo

[Other prominent vendors]
• Atrium Medical
• Global Blood Resources
• Redax
• Sarstedt
• Stryker

[Market driver]
• Rise in cardiac surgeries
• For a full, detailed list, view our report

[Market challenge]
• Limitations of autotransfusion technology
• For a full, detailed list, view our report

[Market trend]
• Development of ultrafiltration systems
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights
• Cardiopulmonary diseases: An overview
• Cardiopulmonary autotransfusion systems: An overview
• Role of autotransfusion in cardiac surgeries
• Cardiopulmonary autotransfusion process

PART 05: Classification of medical devices
• Classification of medical devices

PART 06: Cost analysis
• Cost analysis of cardiopulmonary autotransfusion systems

PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 08: Market segmentation by end-user
• Hospitals
• ASCs

PART 09: Geographical segmentation
• Cardiopulmonary autotransfusion systems market in Americas
• Cardiopulmonary autotransfusion systems market in EMEA
• Cardiopulmonary autotransfusion systems market in APAC

PART 10: Market drivers
• Rise in cardiac surgeries
• Complications of allogenic blood transfusion
• Advances in autotransfusion technology

PART 11: Impact of drivers

PART 12: Market challenges
• Limitations of autotransfusion technology
• Use of allogenic blood transfusion
• Stringent regulatory framework and medical policies

PART 13: Impact of drivers and challenges

PART 14: Market trends
• Development of ultrafiltration systems
• Significant opportunities in emerging countries
• Public awareness

PART 15: Vendor landscape
• Competitive scenario

PART 16: Major vendors
• Advancis Surgical
• Fresenius Kabi
• Haemonetics
• LivaNova
• Medtronic
• Terumo
• Other prominent vendors

PART 17: Appendix
• List of abbreviations

PART 18: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Types of cardiopulmonary diseases
Exhibit 03: Peri-operative period and its different stages
Exhibit 04: History of autotransfusion
Exhibit 05: Autotransfusion systems for other surgeries
Exhibit 06: Process of autotransfusion
Exhibit 07: Components of cardiopulmonary autotransfusion system
Exhibit 08: Cost analysis of cardiopulmonary autotransfusion
Exhibit 09: Cost breakdown of CABG surgery and cardiopulmonary autotransfusion 2015
Exhibit 10: Global cardiopulmonary autotransfusion systems market 2015-2020 ($ millions)
Exhibit 11: Five forces analysis
Exhibit 12: Global cardiopulmonary autotransfusion systems market segmentation by end-user 2015
Exhibit 13: Global cardiopulmonary autotransfusion systems market segmentation by geography 2015
Exhibit 14: Global cardiopulmonary autotransfusion systems market segmentation by geography 2020
Exhibit 15: Global cardiopulmonary autotransfusion systems market segmentation by geography 2015-2020
Exhibit 16: Global cardiopulmonary autotransfusion systems market segmentation by geography 2015-2020 ($ millions)
Exhibit 17: Cardiopulmonary autotransfusion systems market in Americas 2015-2020 ($ millions)
Exhibit 18: Comparison of US healthcare system: Before and after reforms
Exhibit 19: Implements amended in ACA
Exhibit 20: Number of coronary bypass surgeries per 100,000 people in Europe 2013
Exhibit 21: Cardiopulmonary autotransfusion systems market in EMEA 2015-2020 ($ millions)
Exhibit 22: Cardiopulmonary autotransfusion systems market in APAC 2015-2020 ($ millions)
Exhibit 23: Impact of drivers
Exhibit 24: Impact of drivers and challenges
Exhibit 25: Advancis Surgical: Key takeaways
Exhibit 26: Fresenius Kabi: Key products
Exhibit 27: Fresenius Kabi: Key takeaways
Exhibit 28: Haemonetics: Product segmentation by revenue FY2016
Exhibit 29: Haemonetics: Product segmentation by revenue 2015 and FY2016 ($ millions)
Exhibit 30: Haemonetics: Key takeaways
Exhibit 31: LivaNova: Key products
Exhibit 32: LivaNova: Revenue of cardiac surgery segment by geographical segmentation 2015
Exhibit 33: LivaNova: Key takeaways
Exhibit 34: Medtronic: Key product
Exhibit 35: Medtronic: Key takeaways
Exhibit 36: Terumo: Key product
Exhibit 37: Terumo: Key takeaways



【掲載企業】

Advancis Surgical, Fresenius Kabi, Haemonetics, LivaNova, Medtronic, Terumo, Atrium Medical, Global Blood Resources, Redax, Sarstedt, and Stryker.

【レポートのキーワード】

心肺、自己輸血装置、血液、病院

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[心肺用自己輸血装置の世界市場2016-2020]販売に関する免責事項
★調査レポート[心肺用自己輸血装置の世界市場2016-2020]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆